SCHEMBL3609263

SCHEMBL3609263

Cc1ccc2[nH]c(C(=O)NC3CCCNC3)cc2c1C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.52
MAPK1 P28482 1/20 0.46
OPRK1 P41145 1/20 0.46
NPC1 O15118 1/20 0.45
PBK Q96KB5 1/20 0.45
GHSR Q92847 4/20 0.45
CYP1A2 P05177 1/20 0.45
CHEK1 O14757 4/20 0.45
MLLT1 Q03111 1/20 0.45
CDK2AP1 O14519 1/20 0.45
TLR9 Q9NR96 2/20 0.44
TLR8 Q9NR97 2/20 0.44
TLR7 Q9NYK1 2/20 0.44
CHRNA1 P02708 1/20 0.43
CHRNB2 P17787 1/20 0.43
CHRNB4 P30926 1/20 0.43
CHRNA4 P43681 1/20 0.43
SMYD3 Q9H7B4 1/20 0.43
KDM1A O60341 1/20 0.43
PARP1 P09874 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3609261 1.00 RAB9A (0.52) RAB9AMAPK1OPRK1NPC1PBK
SCHEMBL3595497 0.93 SMYD3 (0.50) RAB9ANPC1GHSRCYP1A2MLLT1
SCHEMBL3595499 0.93 SMYD3 (0.50) RAB9ANPC1GHSRCYP1A2MLLT1
SCHEMBL3600227 0.86 PARP1 (0.49) RAB9AMAPK1OPRK1PBKGHSR
SCHEMBL3600224 0.86 PARP1 (0.49) RAB9AMAPK1OPRK1PBKGHSR
SCHEMBL3607941 0.84 SETD2 (0.52) MAPK1OPRK1PBKCHEK1CDK2AP1
SCHEMBL3607939 0.84 SETD2 (0.52) MAPK1OPRK1PBKCHEK1CDK2AP1
SCHEMBL3603432 0.83 KDM4E (0.51) RAB9AMAPK1OPRK1NPC1GHSR
SCHEMBL3603434 0.83 KDM4E (0.51) RAB9AMAPK1OPRK1NPC1GHSR
SCHEMBL3599117 0.81 MAPK1 (0.47) MAPK1OPRK1PBKCHEK1CDK2AP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100035862-A1 NOVEL AZA-CYCLIC INDOLE-2-CARBOXAMIDES AND METHODS OF USE THEREOF ABBOTT LABORATORIES (US) 2010-02-11 US claimed
US-20100035862-A1 NOVEL AZA-CYCLIC INDOLE-2-CARBOXAMIDES AND METHODS OF USE THEREOF ABBOTT LABORATORIES (US) 2010-02-11 US disclosed
WO-2009158375-A1 AZA-CYLIC INDOLE- 2 -CARBOXAMIDES AND METHODS OF USE THEREOF ABBOTT LABORATORIES (US) 2009-12-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100035862-A1 NOVEL AZA-CYCLIC INDOLE-2-CARBOXAMIDES AND METHODS OF USE THEREOF IDO2, IDO1, INMT RAB9A 3211/4885MAPK1 4292/4885OPRK1 609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.